Nurse Practitioner, Adult Health · Newark, NJ
NPI
1659492130
Since 2007
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
150 Bergen St G-118
Newark, NJ, 07103
Phone (973) 972-0570
Groups this clinician bills Medicare through
Medicare paid, 2023
$904
14 services
Medicare patients, 2023
13
Average age 45
Drug cost, 2024
$204K
914 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Martha A Mulvey prescribed most often to Medicare patients was Levetiracetam, with 168 prescriptions and refills. In total Martha A Mulvey wrote 914 Medicare prescriptions that cost $204K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levetiracetam Generic | 168 | 238 | 52 | $4,420 |
| Divalproex Sodium Generic | 79 | 92 | 18 | $3,123 |
| Clobazam Generic | 63 | 63 | 13 | $7,736 |
| Lacosamide Generic | 58 | 64 | 14 | $3,491 |
| Lamotrigine Generic | 48 | 53 | 12 | $385 |
| Phenobarbital Generic | 48 | 48 | Under 11 | $644 |
| Topiramate Generic | 43 | 49 | 12 | $1,657 |
| Oxcarbazepine Generic | 40 | 47 | 13 | $2,156 |
| Carbamazepine Er Carbamazepine | 38 | 42 | Under 11 | $3,694 |
| Keppra Levetiracetam | 23 | 27 | Under 11 | $39K |
| Zonisamide Generic | 22 | 30 | Under 11 | $322 |
| Carbamazepine Generic | 21 | 23 | Under 11 | $1,252 |
| Phenytoin Sodium Extended Generic | 20 | 22 | Under 11 | $206 |
| Valproic Acid Valproic Acid (As Sodium Salt) | 18 | 18 | Under 11 | $575 |
| Depakote Sprinkle Divalproex Sodium | 15 | 20 | Under 11 | $20K |
Brand drugs: 122 claims; generic drugs: 744 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Martha A Mulvey were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.